
In this video, the authors of the study discuss the cost-effectiveness of ultrasound renal denervation (uRDN) for resistant hypertension in the United States. They explore how uRDN, when added to standard care, improves quality-adjusted life years and reduces cardiovascular risks at a favorable cost per QALY.SCAI Experts, Drs. Suzanne Baron, Rod Taylor, and Ajay Kirtane discuss the highlights from this original research article. Read the JSCAI article here: https://www.jscai.org/article/S2772-9303(25)01043-9/fulltext